Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Psychiatry · Premenstrual Dysphoric Disorder

The Biology of PMDD: Sensitivity and Symptom Overlap

At a Glance

PMDD is usually not caused by abnormal estrogen or progesterone levels. Research suggests that some brains are unusually sensitive to normal menstrual-cycle shifts, with ALLO and serotonin pathways contributing to mood symptoms; symptom tracking helps distinguish PMDD from PME.

If you have ever been told that your hormones are “imbalanced” and that a simple supplement will fix them, you may have been misled. For people with Premenstrual Dysphoric Disorder (PMDD), the biological reality is complex. Current research suggests that PMDD is not usually caused by having too much or too little of a specific hormone; instead, the leading scientific model points to an altered cellular sensitivity—an intense reaction in the brain to the normal, cyclical shifts of the menstrual cycle [1][2].

It Is Rarely an “Imbalance”

In most people with PMDD, blood tests for estrogen and progesterone come back within completely typical ranges [3][4]. The issue is believed to lie in how the brain processes these hormones as they rise and fall. It is important to note that there is currently no routine blood test, brain scan, or assay that can measure this “cellular sensitivity” or definitively diagnose PMDD.

The ALLO and GABA-A Hypothesis

After ovulation, the body produces progesterone. A byproduct of this hormone is allopregnanolone (often called ALLO) [5]. In many people, ALLO interacts with GABA-A receptors in the brain to provide a calming, sedative effect [5][6].

The leading research model suggests that in individuals with PMDD, the brain struggles to adapt to the changing levels of ALLO [7][8]. Instead of feeling calm, the brain’s “braking system” for stress responds differently, which may contribute to the intense irritability, anxiety, or despair observed in the luteal phase [9].

The Role of Serotonin

Serotonin is a neurotransmitter involved in regulating mood, sleep, and appetite. Some study-specific research observations have noted that the brain’s serotonin system undergoes cycle-specific changes in those with PMDD [10]. For example, one study observed increased serotonin transporter levels during the premenstrual phase, which could temporarily reduce available serotonin and trigger depressive symptoms [11]. This suspected link helps explain why medications that increase serotonin (SSRIs) are often an effective treatment option [12].

PMDD vs. Premenstrual Exacerbation (PME)

It is critical to distinguish between PMDD and Premenstrual Exacerbation (PME), though it is very possible to have both at the same time [13].

  • PMDD: Symptoms emerge in the luteal phase and become minimal or absent in the postmenstrual week [14][15].
  • PME: This is the worsening of an existing underlying condition—such as Major Depressive Disorder, Bipolar Disorder, Generalized Anxiety Disorder, or ADHD—during the premenstrual window [13][16]. In PME, symptoms worsen before the period but do not fully improve during the rest of the month [17][18].

Because treatment strategies differ, your doctor will use tracking to see if you have a baseline of symptoms throughout the month, which could indicate PME [19][20].

The Look-Alikes: Ruling Out Other Conditions

Before confirming a PMDD diagnosis, your care team may use targeted testing to rule out medical “mimics” that can cause similar symptoms. These include:

  • Thyroid Dysfunction: Hypothyroidism can cause fatigue, depression, and cycle changes [21].
  • Iron-Deficiency Anemia: Low iron can lead to extreme exhaustion and irritability [22].
  • Endometriosis or Dysmenorrhea: Severe pelvic pain and heavy bleeding can cause significant emotional distress [23][24].
  • Perimenopause: The hormonal fluctuations of the transition to menopause can mimic or worsen premenstrual symptoms [25].

Understanding these biological foundations helps move the conversation away from “it’s all in your head” toward recognizing a legitimate physiological response [26].

Common questions in this guide

Is PMDD caused by a hormone imbalance?
Usually, no. Most people with PMDD have estrogen and progesterone levels in typical ranges; the leading model is that the brain reacts unusually strongly to normal cyclical hormone changes. PMDD is diagnosed from the timing and pattern of symptoms rather than a hormone level alone.
What roles do ALLO and GABA-A play in PMDD?
After ovulation, progesterone is converted in part to allopregnanolone, or ALLO. ALLO normally affects GABA-A receptors, which help regulate the brain’s calming response; in PMDD, the brain may adapt differently to changing ALLO levels, contributing to irritability, anxiety, or despair.
How is PMDD different from premenstrual exacerbation?
PMDD symptoms largely appear in the premenstrual luteal phase and become minimal or absent after menstruation. Premenstrual exacerbation, or PME, is a worsening of an existing condition such as depression, bipolar disorder, anxiety, or ADHD, so symptoms can remain at a lower level throughout the month; both patterns can occur together.
Can a blood test confirm PMDD?
No routine blood test, brain scan, or other assay can measure the proposed cellular sensitivity or definitively diagnose PMDD. Clinicians use the repeated timing and pattern of symptoms, often with daily tracking, while tests may help rule out conditions that resemble PMDD.
What other conditions can look like PMDD?
Fatigue, low mood, irritability, or cycle changes can also occur with thyroid dysfunction or iron-deficiency anemia. Severe pelvic pain or heavy bleeding may point to endometriosis or dysmenorrhea, and perimenopause can mimic or worsen premenstrual symptoms. A clinician can decide which evaluations are appropriate.
Why might SSRIs help with PMDD symptoms?
SSRIs increase serotonin signaling and are often effective for PMDD symptoms. The serotonin system may change across the menstrual cycle in PMDD, which is one reason these medicines can help, but the right treatment depends on your symptoms and medical history.

Get notified when new evidence is published on premenstrual tension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Premenstrual Dysphoric Disorder.

    Lanza di Scalea T, Pearlstein T

    The Psychiatric clinics of North America 2017; (40(2)):201-216 doi:10.1016/j.psc.2017.01.002.

    PMID: 28477648
  2. 2

    Premenstrual syndrome: management and pathophysiology.

    Imai A, Ichigo S, Matsunami K, Takagi H

    Clinical and experimental obstetrics & gynecology 2015; (42(2)):123-8.

    PMID: 26054102
  3. 3

    The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.

    Nguyen TV, Reuter JM, Gaikwad NW, et al.

    Translational psychiatry 2017; (7(8)):e1193 doi:10.1038/tp.2017.146.

    PMID: 28786978
  4. 4

    Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.

    Yen JY, Lin HC, Lin PC, et al.

    International journal of environmental research and public health 2019; (16(22)) doi:10.3390/ijerph16224352.

    PMID: 31703451
  5. 5

    Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.

    Hantsoo L, Epperson CN

    Neurobiology of stress 2020; (12()):100213 doi:10.1016/j.ynstr.2020.100213.

    PMID: 32435664
  6. 6

    Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.

    Tiranini L, Nappi RE

    Faculty reviews 2022; (11()):11 doi:10.12703/r/11-11.

    PMID: 35574174
  7. 7

    Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.

    Timby E, Bäckström T, Nyberg S, et al.

    Psychopharmacology 2016; (233(11)):2109-2117 doi:10.1007/s00213-016-4258-1.

    PMID: 26960697
  8. 8

    Transcription of GABAA receptor subunits in circulating monocytes and association to emotional brain function in premenstrual dysphoric disorder.

    Stiernman L, Comasco E, Johansson M, Bixo M

    Translational psychiatry 2025; (15(1)):255 doi:10.1038/s41398-025-03465-6.

    PMID: 40701967
  9. 9

    GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.

    Bäckström T, Bixo M, Strömberg J

    Current psychiatry reports 2015; (17(11)):92 doi:10.1007/s11920-015-0627-4.

    PMID: 26396092
  10. 10

    Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.

    Sacher J, Zsido RG, Barth C, et al.

    Biological psychiatry 2023; (93(12)):1081-1088 doi:10.1016/j.biopsych.2022.12.023.

    PMID: 36997451
  11. 11

    Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA.

    Hantsoo L, Payne JL

    Neuroscience and biobehavioral reviews 2023; (149()):105168 doi:10.1016/j.neubiorev.2023.105168.

    PMID: 37059403
  12. 12

    Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.

    Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB

    The Cochrane database of systematic reviews 2024; (8()):CD001396 doi:10.1002/14651858.CD001396.pub4.

    PMID: 39140320
  13. 13

    Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps.

    Kuehner C, Nayman S

    Current psychiatry reports 2021; (23(11)):78 doi:10.1007/s11920-021-01286-0.

    PMID: 34626258
  14. 14

    Perceived occupational competence and value among university students with premenstrual dysphoric disorder.

    Pekçetin S, Özdinç S, Ata H, et al.

    The British journal of occupational therapy 2022; (85(5)):327-331 doi:10.1177/03080226211020991.

    PMID: 40337666
  15. 15

    Understanding premenstrual exacerbation: navigating the intersection of the menstrual cycle and psychiatric illnesses.

    Lin J, Nunez C, Susser L, Gershengoren L

    Frontiers in psychiatry 2024; (15()):1410813 doi:10.3389/fpsyt.2024.1410813.

    PMID: 39176230
  16. 16

    Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study.

    Broughton T, Lambert E, Wertz J, Agnew-Blais J

    The British journal of psychiatry : the journal of mental science 2025; (226(6)):410-417 doi:10.1192/bjp.2025.104.

    PMID: 40528384
  17. 17

    Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.

    Yen JY, Lin PC, Huang MF, et al.

    International journal of environmental research and public health 2020; (17(3)) doi:10.3390/ijerph17030988.

    PMID: 32033286
  18. 18

    The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory.

    Śliwerski A, Koszałkowska K

    Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111278.

    PMID: 34833154
  19. 19

    Gold-standard evidence and best practice guidance for menstrual cycle-informed clinical care: An overview for clinicians.

    Lambert ER, Nolan LN, Schmalenberger KM

    The British journal of clinical psychology 2026; doi:10.1111/bjc.70066.

    PMID: 42162940
  20. 20

    Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).

    Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al.

    The American journal of psychiatry 2017; (174(1)):51-59 doi:10.1176/appi.ajp.2016.15121510.

    PMID: 27523500
  21. 21

    Premenstrual syndrome, a common but underrated entity: review of the clinical literature

    Dilbaz B, Aksan A

    Journal of the Turkish German Gynecological Association 2021; (22(2)):139-148 doi:10.4274/jtgga.galenos.2021.2020.0133.

    PMID: 33663193
  22. 22

    Premenstrual syndrome in Anand District, Gujarat: A cross-sectional survey.

    Kamat SV, Nimbalkar A, Phatak AG, Nimbalkar SM

    Journal of family medicine and primary care 2019; (8(2)):640-647 doi:10.4103/jfmpc.jfmpc_302_18.

    PMID: 30984687
  23. 23

    Premenstrual Dysphoric Disorder: A Cross-Sectional Study on Prevalence and Awareness Among Medical Students.

    Babour RR, Alharbi SA, Alzahrani SM, et al.

    Cureus 2025; (17(3)):e80917 doi:10.7759/cureus.80917.

    PMID: 40260344
  24. 24

    Menstrual and psychosocial characteristics associated with high-risk of premenstrual dysphoric disorder among university students: a cross-sectional study.

    Lee JJ, Wang T, Park J, et al.

    Women & health 2024; (64(2)):153-164 doi:10.1080/03630242.2024.2304899.

    PMID: 38267033
  25. 25

    Diagnostic validity of premenstrual dysphoric disorder: revisited.

    Naik SS, Nidhi Y, Kumar K, Grover S

    Frontiers in global women's health 2023; (4()):1181583 doi:10.3389/fgwh.2023.1181583.

    PMID: 38090047
  26. 26

    Medical gas-lighting, diagnostic odyssey and self-advocacy among women with premenstrual dysphoric disorder from nine countries.

    Mosalisa M, Roomaney R

    Journal of health psychology 2026; (31(8)):3227-3240 doi:10.1177/13591053251401286.

    PMID: 41540801

This page is for informational purposes only and explains current theories about PMDD biology; it does not constitute medical advice or diagnose PMDD. Discuss persistent or severe symptoms with a qualified clinician.

Guide contents premenstrual tension
Research & Literature
02 Symptoms, Tracking, and Critical Warning Signs 04 The Path to Relief